B · Normal
[Huadong Medicine: The marketing application for the Category 1 new drug Cavigerotromethamine Tablets for long-term weight control in adults was accepted] On November 3, Huadong Medicine (000963.SZ) announced that the company's wholly-owned subsidiary Sinome Huadong received an "Acceptance Notice" issued by the State Food and Drug Administration, and the marketing authorization application for the oral small molecule GLP-1 receptor agonist Cavigeroton Tromethamine Tablets for long-term weight control in adults was accepted. This drug is a Class 1 chemical drug and its specifications include 50mg, 100mg and 200mg.
Comments